{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T14:33:21Z","timestamp":1777214001729,"version":"3.51.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:00:00Z","timestamp":1777161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:00:00Z","timestamp":1777161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chongqing medical scientific research project","award":["2022QNXM002"],"award-info":[{"award-number":["2022QNXM002"]}]},{"name":"Natural Science Foundation of Chongqing, China","award":["cstc2021 jcyj-msxmX0217"],"award-info":[{"award-number":["cstc2021 jcyj-msxmX0217"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"DOI":"10.1186\/s13054-026-05944-8","type":"journal-article","created":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T13:38:52Z","timestamp":1777210732000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mitigating IAPA mortality in the ICU: is it time for personalized immunotherapy?"],"prefix":"10.1186","volume":"30","author":[{"given":"Shuangshuang","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linbo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,26]]},"reference":[{"key":"5944_CR1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13054-025-05328-4","volume":"29","author":"NAF Janssen","year":"2025","unstructured":"Janssen NAF, Vanderbeke L, Jacobs C, et al. Influenza-associated invasive aspergillosis in the ICU: a prospective, multicentre cohort study. Crit Care. 2025;29:100.","journal-title":"Crit Care"},{"issue":"6","key":"5944_CR2","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s00134-021-06431-0","volume":"47","author":"L Vanderbeke","year":"2021","unstructured":"Vanderbeke L, Janssen NAF, Bergmans D, et al. Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial. Intensive Care Med. 2021;47(6):674\u201386.","journal-title":"Intensive Care Med"},{"issue":"1","key":"5944_CR3","doi-asserted-by":"publisher","first-page":"2155584","DOI":"10.1080\/22221751.2022.2155584","volume":"12","author":"YJ Chen","year":"2023","unstructured":"Chen YJ, Lin IF, Chuang JH, Huang HL, Chan TC. Influenza vaccination is associated with a reduced risk of invasive aspergillosis in high-risk individuals in Taiwan: a population-based cohort study. Emerg Microbes Infect. 2023;12(1):2155584.","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"5944_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12916-025-03955-w","volume":"23","author":"ZY Peng","year":"2025","unstructured":"Peng ZY, Hua YT, Huang WT, Wu JS, Ou HT. Reduced risks of influenza-associated hospitalization and complications following vaccination among over 2 million older individuals: a nationwide study using target trial emulation framework. BMC Med. 2025;23(1):157.","journal-title":"BMC Med"},{"issue":"2","key":"5944_CR5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.cmi.2025.09.023","volume":"32","author":"S Yegorov","year":"2026","unstructured":"Yegorov S, Patel OD, Sharma H, et al. Effectiveness of influenza vaccination to prevent severe disease: a systematic review and meta-analysis of test-negative design studies. Clin Microbiol Infect. 2026;32(2):219\u201329.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"5944_CR6","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1080\/21505594.2021.1974327","volume":"12","author":"L Seldeslachts","year":"2021","unstructured":"Seldeslachts L, Duysburgh E, Lavergne SN, et al. Early oseltamivir reduces risk for influenza-associated aspergillosis in a double-hit murine model. Virulence. 2021;12(1):2493\u2013508.","journal-title":"Virulence"},{"issue":"5","key":"5944_CR7","doi-asserted-by":"publisher","first-page":"100289","DOI":"10.1016\/j.xcrm.2021.100289","volume":"2","author":"IMW Dewi","year":"2021","unstructured":"Dewi IMW, Cunha C, Jaeger M, et al. Neuraminidase and SIGLEC15 modulate the host defense against pulmonary aspergillosis. Cell Rep Med. 2021;2(5):100289.","journal-title":"Cell Rep Med"},{"issue":"7","key":"5944_CR8","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/infdis\/jiad001","volume":"227","author":"S Wurster","year":"2023","unstructured":"Wurster S, Pantale\u00f3n Garc\u00eda J, Albert ND, et al. Development of a Corticosteroid-Immunosuppressed Mouse Model to Study the Pathogenesis and Therapy of Influenza-Associated Pulmonary Aspergillosis. J Infect Dis. 2023;227(7):901\u20136.","journal-title":"J Infect Dis"},{"key":"5944_CR9","doi-asserted-by":"crossref","unstructured":"Hatzl S, Kriegl L, Geiger C et al. Empirical antifungal treatment of critically ill patients with influenza-associated acute respiratory distress syndrome: A propensity score weighted observational study. Clin Infect Dis 2025:ciaf507.","DOI":"10.1093\/cid\/ciaf507"},{"issue":"9","key":"5944_CR10","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/S2213-2600(24)00151-6","volume":"12","author":"S Feys","year":"2024","unstructured":"Feys S, Carvalho A, Clancy CJ, Gangneux JP, Hoenigl M, Lagrou K, Rijnders BJA, Seldeslachts L, Vanderbeke L, van de Veerdonk FL, Verweij PE, Wauters J. Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients. Lancet Respir Med. 2024;12(9):728\u201342.","journal-title":"Lancet Respir Med"},{"key":"5944_CR11","doi-asserted-by":"publisher","first-page":"105347","DOI":"10.1016\/j.ebiom.2024.105347","volume":"108","author":"L Seldeslachts","year":"2024","unstructured":"Seldeslachts L, Staels F, Gkountzinopoulou M, et al. Damping excessive viral-induced IFN-\u03b3 rescues the impaired anti-Aspergillus host immune response in influenza-associated pulmonary aspergillosis. EBioMedicine. 2024;108:105347.","journal-title":"EBioMedicine"},{"issue":"827","key":"5944_CR12","doi-asserted-by":"publisher","first-page":"eadw9578","DOI":"10.1126\/scitranslmed.adw9578","volume":"17","author":"L Seldeslachts","year":"2025","unstructured":"Seldeslachts L, Van Bleyenbergh P, Dillen CA, et al. Anakinra restores immunological misfiring that drives influenza-associated pulmonary aspergillosis. Sci Transl Med. 2025;17(827):eadw9578.","journal-title":"Sci Transl Med"},{"issue":"2","key":"5944_CR13","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s00134-022-06958-w","volume":"49","author":"S Feys","year":"2023","unstructured":"Feys S, Heylen J, Carvalho A, Van Weyenbergh J, Wauters J. Variomic Study Group. A signature of differential gene expression in bronchoalveolar lavage fluid predicts mortality in influenza-associated pulmonary aspergillosis. Intensive Care Med. 2023;49(2):254\u20137.","journal-title":"Intensive Care Med"},{"issue":"5","key":"5944_CR14","doi-asserted-by":"publisher","first-page":"e0406124","DOI":"10.1128\/mbio.04061-24","volume":"16","author":"J Pantale\u00f3n Garc\u00eda","year":"2025","unstructured":"Pantale\u00f3n Garc\u00eda J, Wurster S, Albert ND, et al. Immunotherapy with nebulized pattern recognition receptor agonists restores severe immune paralysis and improves outcomes in mice with influenza-associated pulmonary aspergillosis. mBio. 2025;16(5):e0406124.","journal-title":"mBio"},{"key":"5944_CR15","unstructured":"Manchon R, Feys S, Hoenigl M et al. Aspergillus and host-pathogen interaction: focus on treatment-relevant aspects. Clin Microbiol Infect. 2025;S1198\u2013X743 (25) 00428\u20138."}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-05944-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-026-05944-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-05944-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T13:38:54Z","timestamp":1777210734000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13054-026-05944-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,26]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5944"],"URL":"https:\/\/doi.org\/10.1186\/s13054-026-05944-8","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,26]]},"assertion":[{"value":"20 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"204"}}